Table 4.
Summary of published studies reporting 1-3 years outcome after transcatheter aortic valve implantation
| Publication | Route | n | 1 year outcome | 2 years outcome | 3 years outcome |
|---|---|---|---|---|---|
| Moat et al.[7] | Transfemoral | 599 | 18.5% mortality | 22.5% mortality | NA |
| Other routes | 271 | 27.7% mortality | 36.7% mortality | NA | |
| RodésCabau et al.[4] | Transfemoral | 162 | 75% survival | 65% survival | NA |
| Transapical | 177 | 78% survival | 64% survival | NA | |
| Walther et al.[18] | Transapical | 299 | 73% survival | 68% survival | 58% survival |
| Ussia et al.[16] | Transfemoral and transsubclavian | 181 | 23.6% mortality | 30.3% mortality | 34.8% mortality |
| Bleiziffer et al.[17] | Transfemoral and other routes | 227 | 74.5% survival | 64.4% survival | NA |
| Kodali et al.[3] | Transfemoral and transapical | 348 | 24.3% mortality | 33.9% mortality | NA |
| D’Onofrio et al.[8] | Transapical | 774 | 81.7% survival | 76.1% survival | 67.6% survival |
NA: Not available